On November 10, 2023, Dr. Jitendra Singh announced that India is already in the next industrial revolution driven by biotechnology. He stated India is among the few countries with a dedicated Biotechnology policy BiOE3. The Department of Biotechnology (DBT) celebrated the second Foundation Day of BRIC. India's bioeconomy has increased from USD 10 billion to over USD 130 billion, and is projected to reach USD 300 billion in the coming years.
Dr. Singh launched the BRIC-BIRAC Entrepreneur-in-Residence (EIR) Program and inaugurated a one-of-a-kind NHP-ABSL-3 Facility. Dr. Rajesh S. Gokhale highlighted BRIC institutions' achievements: 3,190 publications, 107 patents, 13 commercialized technologies, 2,578 PhD scholars, and 678 post-doctoral fellows. BRIC institutions received 510 Design for BioE3 Challenge applications, 431 from BRIC institutions. A BRIC Bio-Enterprise Innovation Park is being established on a 200-acre campus in Faridabad.
Dr. Kalaivani Ganesan (Scientist-F DBT/Nodal Officer, BRIC), Dr. Anand Deshpande (Founder Chairman and MD, Persistent Systems & Co-Chair, Governing Body, BRIC), Prof. Santishree Dhulipudi Pandit (Vice-chancellor, Jawaharlal Nehru University, New Delhi), and Dr. P. M. Murali (President, Council of Presidents of ABLE; the Founder & Chairman of Jananom Pvt. Ltd.) attended the event. The release was posted by PIB Delhi.
Key Entities Referenced
Department of Biotechnology (DBT): Indian government department responsible for biotechnology research and development.
Biotechnology Research & Innovation Council (BRIC): Institution that promotes biotechnology research and innovation, formed from merged biotechnology institutions.
BioE3: India's dedicated Biotechnology Policy.
BRIC-BIRAC Entrepreneur-in-Residence (EIR) Program: Program to promote entrepreneurship in the biotechnology sector.
Ministry of Science & Technology: The ministry responsible for promoting science and technology in India.
Ministry of Science & Technology
India is already initiated into next industrial
revolution driven by biotechnology: Dr Jitendra
Singh
One of the few countries to have an exclusive dedicated
Biotechnology policy BiOE3, says the Minister
Department of Biotechnology (DBT) celebrates second
Foundation Day of BRIC:
India’s bioeconomy from USD 10 billion risen to over USD
130 billion, projected to reach USD 300 billion in the
coming years: Dr Jitendra Singh
Dr. Jitendra Singh launches BRIC–BIRAC Entrepreneur-in-
Residence (EIR) Program; inaugurates one of its kind NHP-
ABSL-3 Facility
The best of DBT is yet to come, says Dr. Jitendra Singh
Posted On: 10 NOV 2025 5:58PM by PIB Delhi
Speaking at the inauguration of NHP-ABSL-3 Facility during Delivering the inaugural address at the
Second Foundation Day Celebration of "Biotechnology Research & Innovation Council" (BRIC) held
at BRIC–National Institute of Immunology (NII) Union Minister of State (Independent Charge) for
Science & Technology; Earth Sciences; Minister of State for Prime Minister’s Office, Personnel,
Public Grievances, Pensions, Department of Atomic Energy and Department of Space, Dr. Jitendra
Singh observed that India is already initiated into next industrial revolution driven by biotechnology .
The Minister noted that India is one of the few countries to have an exclusive dedicated
Biotechnology policy BiOE3. He commended the Department of Biotechnology (DBT) for emerging
as one of the most dynamic and integrated scientific ecosystems in the Government of India.
Additionally, Dr. Jitendra Singh also launched BRIC–BIRAC Entrepreneur-in-Residence (EIR)
Program. The Union Minister recalled that under the visionary leadership of Prime Minister Shri
Narendra Modi, the decision to merge 14 autonomous biotechnology institutions under a singleumbrella—BRIC, was a transformative reform that strengthened coordination, innovation, and impact
across India’s biotechnology sector.
The Minister said that the integration of institutions under BRIC reflects the spirit of “synergized
working” in Indian science. “The age of silos is over. We have moved towards collaboration across
biotechnology, medical research, agriculture, and data-driven science. BRIC now partners not only
with other science departments but also with IITs, medical institutions, and private industry to
accelerate innovation,” he added.
Dr. Jitendra Singh noted that biotechnology has become the key driver of India’s growth in the Fourth
Industrial Revolution. Referring to the recently launched BioE3 Policy, he said India has positioned
itself among the global frontrunners in bio-innovation. The union minister stated that when the next
phase of global economic growth will be biotechnology-driven, India will not be a follower—it will
be a leader.
The Minister cited BRIC and BIRAC as examples of successful public–private partnership (PPP)
models that have become benchmarks even in global forums. Highlighting India’s progress in
translational research, Dr. Singh mentioned several milestones such as the establishment of advanced
biosafety facilities, breakthroughs in Hemophilia gene therapy, and India’s rising global ranking in
biotechnology. He said, “The vaccine story during the pandemic has transformed India’s image from
being a recipient of global healthcare to being a provider of preventive healthcare solutions.”
Referring to the achievements of DBT and BRIC institutes, the Minister added that Indian biotech
startups, supported by government schemes and the Bio-economy Mission, are contributing
significantly to national GDP. He cited the rapid expansion of India’s bioeconomy from USD 10
billion to over USD 130 billion, projected to reach USD 300 billion in the coming years.
In his address, Dr. Rajesh S. Gokhale, Secretary, DBT and DG, BRIC, highlighted the achievements
of BRIC institutions over the past three years — 3,190 publications, 107 patents, 13 technologies
commercialized, 2,578 PhD scholars, and 678 post-doctoral fellows currently contributing to the
research network. He also noted that BRIC ranks number one in biological sciences in India, as per
Nature’s Pringles Index.
Dr. Gokhale informed that the recently launched Design for BioE3 Challenge has already received
510 applications, with 431 from BRIC institutions, reflecting strong participation from young
researchers nationwide. He also announced the establishment of the BRIC Bio-Enterprise Innovation
Park on a 200-acre campus in Faridabad to promote innovation-led entrepreneurship.
Concluding the event, Dr. Jitendra Singh expressed optimism about the future of Indian
biotechnology, stating, “The best of DBT is yet to come — and so is the best of India. The road to
Viksit Bharat will pass through the corridors of DBT.”
The event was also attended by Dr. Kalaivani Ganesan, Scientist-F DBT/Nodal Officer, BRIC, Dr.
Anand Deshpande, Founder Chairman and MD, Persistent Systems & Co-Chair, Governing Body,
BRIC, Prof. Santishree Dhulipudi Pandit, Vice-chancellor, Jawaharlal Nehru University, New Delhi,
and Dr. P. M. Murali, President, Council of Presidents of ABLE; the Founder & Chairman of Jananom
Pvt. Ltd. along with other dignitaries.*****
NKR/AK/SK
(Release ID: 2188444) Visitor Counter : 469
Read this release in: Urdu , ही